reference/23653306

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/23653306

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase I\|Journal Article\|Multicenter Study\|Research Support, Non-U.S. Gov't
endingPage	1925
issn	0923-7534
issueIdentifier	9
pageRange	1918-1925
publicationName	Annals of oncology : official journal of the European Society for Medical Oncology
startingPage	1918
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a083735aebc9a325683091959d090667 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d80fd9d6962f6d9a01ae345eb8f27b8c http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a6e047475edd20ffd1f8e0ef5d341a37 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d29184df8844e34b460482b1b6dbad96 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_de039a595c12959df2d890555b3f60cb http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d8761cdffba3140c400fa95ff20948c6 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_6b6146e5c8345184bba0dc2e06f60234 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_3448ceaef807777cf4b24cc2d3198ef4 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d4b848928d1c3e5c86d298abb68475f9 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_96cf570ced8226fdba4a84f1214d8954 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_da52c4d24f8811e675b6252a2f93a38b http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b05c23fab98df11c755ba516f5df83c0 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b192fbd0dfb616f69a42d4d74c7b4758 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_82202705d0d3b626e68b75769e9c9cf3 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c7b3a1b2cf8cb6b0436364df7ca19922 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_965842d078f64ba486d5550c85523571 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_1f778fd225f873ed3a7789d3143350f6 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_4b6e8764c77ccb973bb37b81c833df3b
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_191c053e42d603729a92cd9f854bd527 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_cbf76ce8c0ac9292cc60b3ed2e234245 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_9f7ce3dc7505b0cb5fda97401d1ec963 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_87854ff1a79b0e62941f6ebeaa7c9dbe http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f9d878de052832230a3ba6c5a996d396 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_8128de6f3512a514b1a4efdc2a080460
bibliographicCitation	Basu B, Krebs MG, Sundar R, Wilson RH, Spicer J, Jones R, Brada M, Talbot DC, Steele N, Ingles Garces AH, Brugger W, Harrington EA, Evans J, Hall E, Tovey H, de Oliveira FM, Carreira S, Swales K, Ruddle R, Raynaud FI, Purchase B, Dawes JC, Parmar M, Turner AJ, Tunariu N, Banerjee S, de Bono JS, Banerji U. Vistusertib (dual m-TORC1/2 inhibitor) in combination with paclitaxel in patients with high-grade serous ovarian and squamous non-small-cell lung cancer. Ann Oncol. 2018 Sep 01;29(9):1918–25. PMID: 30016392; PMCID: PMC6158767.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_04d6929d026947bacd84ee336dff038c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7ec2db4be76de74ef75d196986669110 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7a036f1cb5a29ce0e37e68844686f0a8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1503-3123 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_429273e5f32d230d0f9aa5c04e037329 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1d6cf22d2f65a90cb0dc22b6f01075b5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3dcfd4eec7c9ce4207d6436f5c3737ed http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fea906d2c3ebf89bc2cd8051cc1f22e2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5ba9f013896a022457a65669fc2be216 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_89503b8510d10e321d3e4d13b7870016 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8e60af12d09c7d56a1972f69f417d054 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b7fdc84912b16c608ac11f8249513d41 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_14ad1e85a4fe06496b85ed06321542e8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dd43f2c5e3b43e7611842d1acb2bda3d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b68bba174c8b9dbac4ee1fe618e04f1e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f9ddfda29c8068dd3b64a9ac2ea5aed1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c813f9256f040d7a06a8e9eb42ddf135 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e34ba3741d174c78f96692ee630627cc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e901fd6deb1103003389fb4cc70de4fa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a08567610c5d9e150b06e6a7b4941123 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cfe8d4eee39eb6e034236704ddfa7a5a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_39bc87ab8c61ada51f1a5c2f1cab1051 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_04b47acb4e908895f5b7552d986cc034 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f8f3f9f864654144497c774fe1c89cc7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9e9582167704f92ac68a5491d0214b71 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a5f5dea2afc8c2f7a1e8583db60fe1c7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_98a84d55aad1f85bcd582546467a097b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c53881fe7db94c934ad5006775532ec3
date	2018-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC6158767 https://pubmed.ncbi.nlm.nih.gov/30016392 https://doi.org/10.1093/annonc/mdy245
isPartOf	https://portal.issn.org/resource/ISSN/0923-7534 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1846
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Vistusertib (dual m-TORC1/2 inhibitor) in combination with paclitaxel in patients with high-grade serous ovarian and squamous non-small-cell lung cancer
discusses	http://id.nlm.nih.gov/mesh/M0018260 http://id.nlm.nih.gov/mesh/M0014072 http://id.nlm.nih.gov/mesh/M0026156 http://id.nlm.nih.gov/mesh/M0029535 http://id.nlm.nih.gov/mesh/M0002327 http://id.nlm.nih.gov/mesh/M0457532 http://id.nlm.nih.gov/mesh/M0579319 http://id.nlm.nih.gov/mesh/M0579317 http://id.nlm.nih.gov/mesh/M000676680
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D009025Q000008 http://id.nlm.nih.gov/mesh/D002289Q000188 http://id.nlm.nih.gov/mesh/D011743Q000008 http://id.nlm.nih.gov/mesh/D008175Q000473 http://id.nlm.nih.gov/mesh/D010051Q000188 http://id.nlm.nih.gov/mesh/D001549Q000008 http://id.nlm.nih.gov/mesh/D000971Q000008 http://id.nlm.nih.gov/mesh/D047428Q000008
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D002289Q000473 http://id.nlm.nih.gov/mesh/D011743Q000009 http://id.nlm.nih.gov/mesh/D020714 http://id.nlm.nih.gov/mesh/D009025Q000493 http://id.nlm.nih.gov/mesh/D001549Q000009 http://id.nlm.nih.gov/mesh/D019893Q000378 http://id.nlm.nih.gov/mesh/D008175Q000188 http://id.nlm.nih.gov/mesh/D011743Q000493 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D009025Q000009 http://id.nlm.nih.gov/mesh/D000076225Q000037 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D017239Q000008 http://id.nlm.nih.gov/mesh/D001549Q000493 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D010051Q000473 http://id.nlm.nih.gov/mesh/D017239Q000009 http://id.nlm.nih.gov/mesh/D000076222Q000037 http://id.nlm.nih.gov/mesh/D000971Q000009 http://id.nlm.nih.gov/mesh/D047428Q000493 http://id.nlm.nih.gov/mesh/D047428Q000009 http://id.nlm.nih.gov/mesh/D004334 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D066066 http://id.nlm.nih.gov/mesh/D010766Q000187
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8752 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7660 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_17f32aee125cfd94e90fe691ef11a1e8 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25262792 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_532369210541336568b55b63b6b6dd0e http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f23da35a23be1387249189adc219228a http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9002f7b62e7223e85a4962c6cd6d9c18 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10931 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7706

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID223366032

Total number of triples: 127.